PyInvesting

Market research

S66.AU Star Combo Pharma Limited

AU AUD Consumer Defensive

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
19M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
2.1%
Beta
0.35

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Star Combo Pharma Limited is currently in a long term downtrend where the price is trading 15.7% below its 200 day moving average.

From a valuation standpoint, the stock is 85.3% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 1.0.

Star Combo Pharma Limited's total revenue sank by 30.3% to $15M since the same quarter in the previous year.

Its net income has increased by 143.0% to $530K since the same quarter in the previous year.

Finally, its free cash flow grew by 0.0% to $-2M since the same quarter in the previous year.

Based on the above factors, Star Combo Pharma Limited gets an overall score of 3/5.